MK591 (Quiflapon), a 5-lipoxygenase inhibitor, kills pancreatic cancer cells via downregulation of protein kinase C-epsilon
Article in Frontiers in Oncology (April 2024)
The most recent citing publications are shown below. View all 123 publications that cite this research output on Dimensions.
Cross talk of tumor protein D52 (TPD52) with KLF9, PKCε, and MicroRNA 223 in ovarian cancer
Article in Journal of Ovarian Research (October 2023)
Exploring the prognostic significance of PKCε variants in cervical cancer
Article in BMC Cancer (September 2023)